JP5199994B2 - 糖尿病の予測手段および予測方法 - Google Patents

糖尿病の予測手段および予測方法 Download PDF

Info

Publication number
JP5199994B2
JP5199994B2 JP2009500866A JP2009500866A JP5199994B2 JP 5199994 B2 JP5199994 B2 JP 5199994B2 JP 2009500866 A JP2009500866 A JP 2009500866A JP 2009500866 A JP2009500866 A JP 2009500866A JP 5199994 B2 JP5199994 B2 JP 5199994B2
Authority
JP
Japan
Prior art keywords
acid
metabolite
diabetes
predisposition
metabolites
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2009500866A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009530627A (ja
Inventor
ベタン，ビアンカ
ブッシュ，クリスティーナ
ヴィーマー，ジャン
ギプマンズ，マーティン
リーボールド，エドガー
シュプランガー，ヨッヘン
ボベルト，トーマス
フリードリッヒ ヘルマン パイフェル，アンドレアス
Original Assignee
メタノミクス ゲーエムベーハー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06111705A external-priority patent/EP1837657A1/fr
Application filed by メタノミクス ゲーエムベーハー filed Critical メタノミクス ゲーエムベーハー
Publication of JP2009530627A publication Critical patent/JP2009530627A/ja
Application granted granted Critical
Publication of JP5199994B2 publication Critical patent/JP5199994B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]
    • Y10T436/144444—Glucose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2009500866A 2006-03-24 2007-03-21 糖尿病の予測手段および予測方法 Expired - Fee Related JP5199994B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP06111705.7 2006-03-24
EP06111705A EP1837657A1 (fr) 2006-03-24 2006-03-24 Moyens et procédé pour prédire ou diagnostiquer un diabète
EP06120273 2006-09-07
EP06120273.5 2006-09-07
PCT/EP2007/052692 WO2007110358A2 (fr) 2006-03-24 2007-03-21 Moyen et méthode permettant de

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012247306A Division JP5579819B2 (ja) 2006-03-24 2012-11-09 糖尿病の予測手段および予測方法

Publications (2)

Publication Number Publication Date
JP2009530627A JP2009530627A (ja) 2009-08-27
JP5199994B2 true JP5199994B2 (ja) 2013-05-15

Family

ID=38016918

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2009500866A Expired - Fee Related JP5199994B2 (ja) 2006-03-24 2007-03-21 糖尿病の予測手段および予測方法
JP2009500865A Expired - Fee Related JP5167239B2 (ja) 2006-03-24 2007-03-21 糖尿病の検出手段および検出方法
JP2012228718A Ceased JP2013057672A (ja) 2006-03-24 2012-10-16 糖尿病の検出手段および検出方法
JP2012247306A Expired - Fee Related JP5579819B2 (ja) 2006-03-24 2012-11-09 糖尿病の予測手段および予測方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2009500865A Expired - Fee Related JP5167239B2 (ja) 2006-03-24 2007-03-21 糖尿病の検出手段および検出方法
JP2012228718A Ceased JP2013057672A (ja) 2006-03-24 2012-10-16 糖尿病の検出手段および検出方法
JP2012247306A Expired - Fee Related JP5579819B2 (ja) 2006-03-24 2012-11-09 糖尿病の予測手段および予測方法

Country Status (10)

Country Link
US (2) US8216847B2 (fr)
EP (6) EP2339346B1 (fr)
JP (4) JP5199994B2 (fr)
CN (1) CN101438168B (fr)
AR (2) AR060121A1 (fr)
AT (2) ATE493661T1 (fr)
CA (2) CA2647197A1 (fr)
DE (2) DE602007011588D1 (fr)
ES (4) ES2525345T3 (fr)
WO (2) WO2007110357A2 (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2525345T3 (es) * 2006-03-24 2014-12-22 Metanomics Gmbh Procedimiento de diagnóstico de diabetes de tipo II
EP2164977B1 (fr) 2007-07-17 2013-10-30 Metabolon, Inc. Biomarqueurs du prédiabète et méthodes d'utilisation de ces biomarqueurs
WO2009054350A1 (fr) * 2007-10-25 2009-04-30 Ajinomoto Co., Inc. Méthode d'évaluation d'une intolérance au glucose
EP2286236B1 (fr) 2008-05-28 2016-04-20 Basf Se Procédés d'estimation de la toxicité hépatique
BRPI0912175A2 (pt) 2008-05-28 2015-10-06 Basf Se métodos para diagnosticar indução de enzima do fígado, para determinar se um composto é capaz de induzir indução de enzima do fígado em um indivíduo, e para identificar uma substância para tratar indução de enzima do fígado
CA2724422A1 (fr) 2008-05-28 2009-12-23 Basf Se Moyens et procedes d'evaluation de proliferation peroxysomale accrue
EP2313773A1 (fr) * 2008-07-15 2011-04-27 Metanomics Health GmbH Moyens et méthodes de diagnostic d un pontage gastrique et des pathologies liées à celui-ci
DE102009013914B4 (de) * 2009-03-19 2011-05-05 Bruker Daltonik Gmbh Kalibriersubstanzen für Atmosphärendruck-Ionenquellen
ES2432534T3 (es) 2009-03-24 2013-12-04 Anamar Ab Perfiles metabólicos
US20120122243A1 (en) * 2009-06-04 2012-05-17 Charite Universitatsmedizin Berlin Means and method and means for diagnosing prostate carcinomas
CA2769889A1 (fr) * 2009-08-13 2011-02-17 Basf Se Moyens et procedes pour diagnostiquer des desordres de la thyroide
US8367359B1 (en) * 2009-10-23 2013-02-05 The United States Of America, As Represented By The Secretary Of Agriculture Metabolic biomarkers for diabetes and insulin resistance
ES2728120T3 (es) * 2010-01-29 2019-10-22 Metanomics Gmbh Medios y procedimientos para diagnosticar insuficiencia cardíaca en un sujeto
WO2012013667A1 (fr) * 2010-07-30 2012-02-02 Technische Universität Graz Analyse d'analytes
WO2012051463A2 (fr) * 2010-10-14 2012-04-19 The Regents Of The University Of California Profil métabolomique de l'urine en cas de néphropathie diabétique
AU2011346553A1 (en) * 2010-12-23 2013-07-11 Metanomics Health Gmbh Means and method for predicting diabetes
US20130101984A1 (en) * 2011-10-20 2013-04-25 The Washington University Methods of detecting sleepiness
JP2015517090A (ja) * 2012-03-09 2015-06-18 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 鉄吸収障害又はエネルギー代謝障害に関連する障害を評価する手段及び方法
US9361429B2 (en) 2012-06-08 2016-06-07 Liposcience, Inc. Multi-parameter diabetes risk evaluations
US9470771B2 (en) 2012-06-08 2016-10-18 Liposcience, Inc. NMR measurements of NMR biomarker GlycA
US9928345B2 (en) 2012-06-08 2018-03-27 Liposciences, Inc. Multiple-marker risk parameters predictive of conversion to diabetes
JP6282642B2 (ja) 2012-06-27 2018-02-21 メタノミクス ヘルス ゲーエムベーハー 糖尿病薬を同定する方法
ES2686542T3 (es) * 2012-10-18 2018-10-18 Metanomics Gmbh Medios y procedimientos para determinar una cantidad normalizada de aclaramiento de un biomarcador de enfermedad metabólica en una muestra
JP6404834B2 (ja) * 2013-01-31 2018-10-17 メタボロン，インコーポレイテッド インスリン抵抗性の進行に関連するバイオマーカー及びこれを使用する方法
KR102362357B1 (ko) * 2013-04-09 2022-02-15 아지노모토 가부시키가이샤 생활습관병 지표의 평가 방법, 생활습관병 지표 평가 장치, 생활습관병 지표 평가 방법, 생활습관병 지표 평가 프로그램, 생활습관병 지표 평가 시스템, 및 정보통신 단말장치
CN103616465A (zh) * 2013-10-28 2014-03-05 浙江大学 血液相关脂肪酸谱的建立方法
US20150323520A1 (en) * 2014-05-07 2015-11-12 The Trustees Of The Stevens Institute Of Technology Diagnosis of kidney transplant acute rejection
JP6773951B2 (ja) * 2014-05-30 2020-10-21 学校法人東京医科大学 唾液試料の調製方法
WO2016138232A1 (fr) * 2015-02-26 2016-09-01 Wisconsin Alumni Research Foundation Procédés de prédiction de dysfonctionnement glucorégulatoire
KR20170002318A (ko) * 2015-06-29 2017-01-06 고려대학교 산학협력단 대사체 분석을 이용한 당뇨병 조기 진단용 조성물
CN106979982B (zh) * 2016-01-19 2021-01-05 上海市第六人民医院 一种用于糖尿病风险预测、治疗评价的方法及试剂盒
CN105784829A (zh) * 2016-04-06 2016-07-20 深圳市老年医学研究所 2型糖尿病肾虚证唾液蛋白指纹图谱分子诊断模型建立方法
CN105699663A (zh) * 2016-04-06 2016-06-22 深圳市老年医学研究所 2型糖尿病唾液蛋白指纹图谱分子诊断模型建立方法
CN109154619A (zh) * 2016-05-17 2019-01-04 国立大学法人大阪大学 用于判定糖尿病的血液试样的分析方法及系统
EP3602605A4 (fr) * 2017-03-31 2020-12-30 Metabolon, Inc. Analyse complète et quantitative de lipides et de tocophérols
CN110998331A (zh) * 2017-08-17 2020-04-10 雀巢产品有限公司 针对儿童期前驱糖尿病的青春前期标志物
CN108362804B (zh) * 2018-02-27 2019-01-29 山东英盛生物技术有限公司 一种检测血液样品中dha含量的方法及试剂盒
CN109507337B (zh) * 2018-12-29 2022-02-22 上海交通大学医学院附属新华医院 一种基于血尿中代谢产物预测甘地胶囊治疗糖尿病肾病机制的新方法
CN111443143B (zh) * 2020-04-30 2022-04-29 宁波市产品食品质量检验研究院(宁波市纤维检验所) 一种快速测定乳粉中胆固醇含量的方法
CN114216851A (zh) * 2020-11-27 2022-03-22 四川大学华西医院 一种基于表面增强拉曼光谱技术的急性胰腺炎评估装置
KR102583808B1 (ko) * 2021-03-05 2023-09-26 경희대학교 산학협력단 눈물을 이용한 당뇨병의 진단 방법 및 키트
CN115032286B (zh) * 2021-03-08 2024-08-13 江成鸿 组合物在制备诊断婴幼儿血管瘤和/或监测其进展及预后的药物中的应用及试剂盒和药物
CN114324662B (zh) * 2021-12-30 2022-09-16 中南大学 用于诊断或预防糖尿病的血清生物标志物的应用
CN114965753B (zh) * 2022-05-13 2026-03-31 重庆医科大学附属第一医院 一种lgals3bp蛋白丰度检测试剂在制备妊娠期糖尿病泪液诊断试剂中的应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540884A (en) 1982-12-29 1985-09-10 Finnigan Corporation Method of mass analyzing a sample by use of a quadrupole ion trap
AU590883B2 (en) * 1985-05-28 1989-11-23 Nippon Kayaku Kabushiki Kaisha Method of quantitative assay for 1,5-anhydroglucitol
JP2540349B2 (ja) * 1988-01-18 1996-10-02 日本化薬株式会社 腎性糖尿検査方法
DK0455783T3 (da) * 1989-11-30 1996-04-01 Croda Int Plc Anvendelse af nervonsyre og langkædede fedtsyrer til behandlingen af demyeliniserende sygdomme
DE4242794A1 (en) * 1991-12-18 1993-06-24 Nitto Boseki Co Ltd Quantitative automated determn. of 1,5-anhydro:glucitol - using pyranose oxidase from Basidiomycetes fungi no.52
US5624804A (en) * 1991-12-20 1997-04-29 The Rockefeller University Immunochemical detection of In vivo advanced glycosylation end products
US5397894A (en) 1993-05-28 1995-03-14 Varian Associates, Inc. Method of high mass resolution scanning of an ion trap mass spectrometer
JPH0870893A (ja) * 1994-09-02 1996-03-19 Nippon Kayaku Co Ltd 犬の糖尿病診断法、１，５−アンヒドログルシトールの定量法及びキット
JP3579549B2 (ja) * 1995-10-24 2004-10-20 株式会社トクヤマ 糖尿病または糖尿病合併症用マーカーとしての使用
KR19990007908A (ko) * 1996-02-20 1999-01-25 히라다다다시 1,5-안히드로글루시톨의 정량법
US5965449A (en) * 1996-07-03 1999-10-12 Forbes Medi-Tech, Inc. Method of assessing risk for cardiovascular disease and other disorders and phytosterol-based compositions useful in preventing and treating cardiovascular disease and other disorders
US5871949A (en) * 1996-12-04 1999-02-16 Daiichi Pure Chemicals Co., Ltd. Method of quantitative assay for 1,5-anhydroglucitol and reagent for quantitative assay
JP3129250B2 (ja) * 1997-09-10 2001-01-29 株式会社ミルス生命科学研究所 尿の化学分析方法
US6309852B1 (en) * 1998-12-11 2001-10-30 Kyowa Medex Co., Ltd. Method and reagent for quantitative determination of 1,5-anhydroglucitol
EP1171778B1 (fr) * 1999-04-22 2006-03-01 Liposcience, Inc. Methode utilisant l'irm pour determiner le risque de developper un diabete non insulino-dependant
US6140067A (en) * 1999-04-30 2000-10-31 Mitokor Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus
JP2001330599A (ja) * 2000-05-24 2001-11-30 Shimazu S D Kk Ｇｃ／ｍｓによる代謝異常スクリーニング診断装置
US20020068310A1 (en) * 2000-10-11 2002-06-06 Mihoko Sasaki Method and reagant for quantitative determination of 1,5-anhydroglucitol
ES2173049B1 (es) * 2001-03-28 2004-01-16 Oleoyl Estrone Developments S Monoester de acido graso y estrogeno como agente antidiabetico e hipolipemiante.
WO2003005628A2 (fr) * 2001-07-06 2003-01-16 Lipomics Technologies, Inc. Methodes permettant de generer, visualiser, interpreter et utiliser une base de donnees quantitatives de metabolites
WO2003027296A1 (fr) * 2001-09-20 2003-04-03 Plantech Research Institute Genes intervenant dans la synthese d'acide gras presentant une liaison double conjuguee trans-11-, cis-13-, et utilisation desdits genes
EP1438420B1 (fr) * 2001-09-24 2009-09-16 Lipomics Technologies, Inc. Procede d'utilisation de donnees quantitatives concernant le metabolome lipidique
EP1481416B1 (fr) 2002-02-28 2016-06-15 Metanomics GmbH & Co. KGaA Procede de spectrometrie de masse pour analyser des melanges de substances
US20040024065A1 (en) * 2002-03-11 2004-02-05 Watkins Steven M. Novel metabolic targets and markers
US20040132819A1 (en) * 2002-08-06 2004-07-08 Nancy Auestad Appetite control method
JP2004097134A (ja) * 2002-09-11 2004-04-02 Univ Hiroshima 鎖長延長酵素による長鎖脂肪酸の合成法
JP2007523849A (ja) * 2003-05-31 2007-08-23 フォーブス メディ−テック インコーポレーテッド １種以上のフィトステロール及び／又はフィトスタノール、及びグルコマンナンを含む組成物、及びｉｉ型糖尿病を有する又は有さない個体の脂質疾患の治療における該組成物の使用。
EP1718327B1 (fr) * 2003-06-20 2015-01-07 University of Florida Biomarqueurs permettant de differencier des diabetes de types 1 et 2
JP4066259B2 (ja) * 2003-09-11 2008-03-26 財団法人大阪産業振興機構 軟体動物由来廃棄物の処理方法
CN101010031A (zh) * 2004-02-17 2007-08-01 波蒂生物公司 用于整合个人化临床试验结果和营养治疗的网络和方法
US20050202521A1 (en) * 2004-03-10 2005-09-15 Albert Crum Methods of assessing the need for and the effectiveness of therapy with antioxidants
WO2005124348A1 (fr) * 2004-06-09 2005-12-29 Becton, Dickinson And Company Detecteur d'analytes multiples
US20090232916A1 (en) * 2004-08-09 2009-09-17 Avidor Shulman Food products for diabetics
WO2006073195A1 (fr) * 2005-01-07 2006-07-13 Biomarker Science Co., Ltd Procede de prediction ou de diagnostic du diabete et kit de prediction ou diagnostic du diabete
ES2525345T3 (es) * 2006-03-24 2014-12-22 Metanomics Gmbh Procedimiento de diagnóstico de diabetes de tipo II
EP2164977B1 (fr) * 2007-07-17 2013-10-30 Metabolon, Inc. Biomarqueurs du prédiabète et méthodes d'utilisation de ces biomarqueurs

Also Published As

Publication number Publication date
US8216848B2 (en) 2012-07-10
ATE493661T1 (de) 2011-01-15
CN101438168A (zh) 2009-05-20
JP2013076703A (ja) 2013-04-25
JP5167239B2 (ja) 2013-03-21
WO2007110358A2 (fr) 2007-10-04
ATE493660T1 (de) 2011-01-15
EP2005189B1 (fr) 2010-12-29
EP2008108A2 (fr) 2008-12-31
EP2369346A3 (fr) 2011-11-02
WO2007110357A2 (fr) 2007-10-04
AR060120A1 (es) 2008-05-28
EP2005189A2 (fr) 2008-12-24
EP2339346B1 (fr) 2014-09-03
JP2009530626A (ja) 2009-08-27
EP2336782B1 (fr) 2014-08-27
JP2013057672A (ja) 2013-03-28
JP2009530627A (ja) 2009-08-27
WO2007110358A3 (fr) 2007-11-15
ES2522815T3 (es) 2014-11-18
CA2647122A1 (fr) 2007-10-04
US20100163720A1 (en) 2010-07-01
CN101438168B (zh) 2013-10-16
EP2330423A1 (fr) 2011-06-08
AR060121A1 (es) 2008-05-28
EP2008108B1 (fr) 2010-12-29
EP2369346A2 (fr) 2011-09-28
DE602007011592D1 (de) 2011-02-10
ES2522818T3 (es) 2014-11-18
EP2330423B1 (fr) 2014-10-01
ES2522816T3 (es) 2014-11-18
EP2336782A1 (fr) 2011-06-22
US8216847B2 (en) 2012-07-10
EP2339346A2 (fr) 2011-06-29
JP5579819B2 (ja) 2014-08-27
EP2339346A3 (fr) 2011-10-19
DE602007011588D1 (de) 2011-02-10
EP2369346B1 (fr) 2014-08-27
CA2647197A1 (fr) 2007-10-04
ES2525345T3 (es) 2014-12-22
US20100236321A1 (en) 2010-09-23
WO2007110357A3 (fr) 2007-11-15

Similar Documents

Publication Publication Date Title
JP5579819B2 (ja) 糖尿病の予測手段および予測方法
ES2358454T3 (es) Medios y método para predecir diabetes tipo ii.
JP5933432B2 (ja) 前立腺癌を診断する手段と方法
AU2009259540B2 (en) Means and methods for assessing liver toxicity
CA2822216A1 (fr) Moyen et methode de prediction du diabete
JP2015042985A (ja) 肝酵素誘導を評価する手段及び方法

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100316

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110719

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20110720

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111013

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20111020

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111114

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20111121

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120119

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120710

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121005

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121015

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121109

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130115

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130208

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160215

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees